Yerassyl Ibragim

2 ta ish

Medical Center for Cardiology and Internal Medicine & quot; Kazakhstan

1. A Comprehensive Analysis of Visfatin Drug in Type 2 Diabetes, Insulin Resistance, and Cardiovascular Disease

   ENRIQUE VALDEZ SAENZ, Azamatov Golibkhon, Yerassyl Ibragim

   MaqolaAdipokines, Inflammation, and Metabolic DiseasesJournal of Prevention Diagnosis and Management of Human Diseases20230 iqtibos

   ABIABI:AkademIndex/openalex/2023.article.003219

2. A comprehensive analysis of visfatin drug in type 2 diabetes, insulin resistance, and cardiovascular disease

   ENRIQUE VALDEZ SAENZ, Azamatov, Yerassyl Ibragim

   MaqolaAdipokines, Inflammation, and Metabolic DiseasesJournal of Prevention Diagnosis and Management of Human Diseases20230 iqtibos

   ABIABI:AkademIndex/openalex/2023.article.014125